Clinical Trials Logo

MRI clinical trials

View clinical trials related to MRI.

Filter by:

NCT ID: NCT04782531 Active, not recruiting - MRI Clinical Trials

Variations of Portal Flow During the Respiratory Cycle in Healthy Volunteers

RESPIFLUX
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The analysis of portal vein blood flow is important when assessing the severity and progression of liver disease. It is important to understand normal liver regulation in order to appreciate the evaluation of the effect of treatment during the disease progression. The influence of respiration on hepatic hemodynamics is still poorly understood, although some studies have shown a significant impact. The purpose of this project is to quantify the blood flow variations in the portal vein at different positions during the respiratory cycle by using a fast MRI sequence and an Echo Planar (EPI) acquisition.

NCT ID: NCT04735276 Not yet recruiting - MRI Clinical Trials

MRI Study of the Gastric Insufflation After High-flow Nasal Oxygen (HFNO)

Start date: April 1, 2021
Phase:
Study type: Observational

HFNO CAN BE USED AS A PREOXYGENATION TECHNIQUE BUT IS IT A SAFE TECHNIQUE IN TERMS OF GASTRIC INSUFFLATION?

NCT ID: NCT04707170 Completed - MRI Clinical Trials

MRI Exploration of Meningeal Inflammatory Disease

EIME
Start date: June 16, 2021
Phase:
Study type: Observational

Patients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which two additional sequences of 6 minutes duration will be added. The MRI of routine care includes at least the following sequences: - 3D T1 TFE 1.0 isotropic (2 minutes) - T2 TSE (2 minutes) - 3D FLAIR pre-injection (opt) (3 minutes) - 3D FLAIR post-injection (3 minutes) As part of the research, the following sequences will be acquired: - FABIR pre-injection (3 minutes) - FABIR post-injection (3 minutes) Patients hospitalized for a foreseeable duration of at least 24 hours will be offered participation in the longitudinal tab of the study, for which four non-injected MRI examinations will be performed. The examinations will be carried out remotely from the injected MRI (1h, 2h, 12h-15h, 24h-36h). These exams dedicated to research will include the following sequences for a maximum of 8 minutes: - 3D T1 TFE 1.0 isotropic (2 minutes) - 3D FLAIR (3 minutes) - FABIR (3 minutes)

NCT ID: NCT04692259 Recruiting - MRI Clinical Trials

May the Risk of PHLF be Predicted With Preoperative Liver Gadoxetate MRI

MR-Predict
Start date: December 29, 2020
Phase: N/A
Study type: Interventional

Post hepatectomy liver failure (PHLF) is one of the most severe complications after liver re-section. Preoperative evaluation of liver function is complicated and imprecise. The volume and function needed for each individual patient is unknown and the methods used for evaluation are uncertain. Preoperative MRI with Gadolinium may give dynamic information regarding liver function correlating with postoperative liver failure. A retrospective analysis will be performed regarding this topic.

NCT ID: NCT04652661 Completed - Dexmedetomidine Clinical Trials

Intranasal Dexmedetomidine Versus Intranasal Midazolam for MRI In Pediatrics

Start date: December 10, 2020
Phase: Phase 4
Study type: Interventional

An increasing number of studies have reported the use of dexmedetomidine in clinical practice. However, few studies have reported on the intranasal use of dexmedetomidine in radiological procedures The aim of this work is to compare the efficacy and safety of intranasal dexmedetomidine and intranasal midazolam in pediatrics undergoing MRI.

NCT ID: NCT04481542 Recruiting - MRI Clinical Trials

Aortic Dissection With 4-dimensional Phase-contrast Magnetic Resonance Imaging

Start date: March 1, 2018
Phase:
Study type: Observational

We prospectively collected information on consecutive patients who had been evaluated using 4D PC-MRI for aortic pathology in a tertiary hospital between April 2018 and Feb 2020. Patients were eligible for inclusion in the study if they had a clinical indication for CTA of aortic dissections.

NCT ID: NCT04457024 Completed - Hyperlipidemia Clinical Trials

Tennis Elbow Patients Undergoing Closed Therapy Can Easily Cause Tendon Tear

Start date: January 1, 2020
Phase:
Study type: Observational [Patient Registry]

To explore whether there is a difference in the rate of tendon tear after hyperlipemia in tennis elbow patients and those with normal blood lipids after closed treatment, which provides clues for further exploration of its mechanism. 1. Collect data from 108 cases of tennis elbow patients treated at the Institute of Sports Medicine, Peking University Third Hospital from January 2010 to December 2018 at the Institute of Sports Medicine, Peking University Third Hospital. Statistics included the sex, age, BMI, number of closures, total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein. 2. Retrieve the MRI imaging data of the above-mentioned patients, and use the extensor tendon at the humerus to see if there is a tear as an observation indicator. Analyze the difference of tendon tear after closed treatment in patients with high blood fat and normal blood fat.

NCT ID: NCT04392609 Recruiting - Rectal Cancer Clinical Trials

Predicting Locally Advanced Rectal Cancer Response to NCT and NCRT With MRI

Start date: January 15, 2020
Phase:
Study type: Observational

This trial was designed to to study whether there is a difference in MRI image evaluation between NCRT and NCT, and try to build a model to predict the efficacy of neoadjuvant therapy by combining multiple imaging indexes.

NCT ID: NCT04369755 Recruiting - MRI Clinical Trials

MR7T-Healthy-PTX : Brain Exploration in Magnetic Resonance Imaging in Parallel Transmission Mode (pTX) at 7 Tesla

Start date: June 25, 2020
Phase: N/A
Study type: Interventional

Magnetic resonance imaging (MRI) is a non-invasive imaging modality used in routine clinical practice for clinical diagnosis by visualizing the anatomical structure and in vivo function of certain organs. The development of ultra-high field MRI systems with 7.0-T or higher, gives access to a new field of exploration of the human body by improving the speed of acquisition but also a better signal-to-noise ratio (SNR) and better resolution. In order to fully exploit the potential of these ultra-high field MRI scanners, various technical issues must be adressed. Indeed, the non-uniformity of the transmission field is one of them leading to non-uniform images with spatially varying contrast. Thus the pTX (parallel transmission) mode using multiple transmission channels allows spatial and temporal control over the RF waves.

NCT ID: NCT04292301 Completed - MRI Clinical Trials

MRI Assessing Clinical Usability of STrategically Acquired Gradient Echo on Human Participants

STAGE
Start date: June 30, 2020
Phase: N/A
Study type: Interventional

The study's purpose is to validate STAGE images and, when applicable, their equivalence to conventional MRI through an assessment by a trained certified neuroradiologist in a clinical setting. For STAGE images without conventional equivalent, the neuroradiologist will determine if their contrasts, intensities, and quality are sufficient and meet expectations for images used in radiological reads of the brain. The study is a multi-center study in which STAGE can be assessed at sites with different MRI manufacturers and field strengths. Site names will be made available to the collaborators and participants. The sponsor is based out of Michigan, while participating sites may be located in other states. Any funding for the study will come from an industry source, SpinTech, Inc.